small molecule

VARITHENA

POLIDOCANOL

Loss of exclusivityMay 2032latest FDA-listed patent expiry
CompanyBOSTON SCIENTIFIC CORP

Drug detail

Brand nameVARITHENA
Active ingredientPOLIDOCANOL
Strength180MG/18ML (10MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2013
Marketing statusRX

Listed patents

PatentExpiresType
9480652May 2032product
7814943November 2027product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

VARITHENA patent cliff — loss of exclusivity May 2032 | CliffBio